Endocrine Pharmacology Flashcards
Give example of a Biguanide
Metformin
Indications of Biguanide (Metformin)
Treat DMT2
first choice medication for control of blood glucose, alone or in combination with other hypoglycaemics such as sulphonyl ureas or insulin
Mechanisms of Biguanide (Metformin)
- Lowers blood glucose by increasing response to insulin
- suppresses hepatic glycogenolysis and gluconeogenesis
- increases glucose uptake and utilisation by skeletal muscle and suppresses intestinal glucose absorption
- DOES NOT cause hypoglycaemia as does not stimulate pancreas
- Reduces weight gain and can induce weight loss, which can prevent worsening of insulin resistance
Does Biguanide (Metformin) cause hypoglycaemia?
No as does not stimulate pancreas
Adverse effects/contraindications of Biguanide (Metformin)
- GI disturbance (weight loss)
- Lactic acidosis can occur in intercurrent lines such as renal or hepatic impairment or cardiac failure
- Contraindicated in severe renal impairment
- should be withheld in acute kidney injury and severe tissue hypoxia
- used with care in hepatic impairment and alcohol intoxication
- Can interact with IV contrast media for scan so must be withheld before these investigations
- Use with caution with other drugs that may impact renal function i.e. ACE inhibitors, diuretics or NSAIDs
- Prednisolone, thiazide and loop diuretics elevate blood glucose and may reduce efficacy of metformin
What drugs are contraindicated for Biguanides (Metformin)
ACE inhibitors
Diuretics
NSAIDs
(others that may impair renal function)
Prednisolone
Thiazide
Loop diuretics
(elevate blood glucose)
Give example of a sulphonylurea
Gliclazide
Glipizide
Indications of sulphonylurea (gliclazide)
DMT2
single agent to control blood glucose and reduce complications where metformin is contraindicated/not tolerated
- Can be used in combination with metformin and other hypoglycaemics in uncontrolled glucose levels
Mechanisms of sulphonylureas (gliclazide)
- Lower blood glucose by stimulating pancreatic insulin secretion
- They block ATP dependent K+ channels in pancreatic beta cell membranes, causing depolarisation of the cell membrane and opening of voltage gated Ca2+ channels thereby stimulating insulin secretion
(Only effective in patients with residual pancreatic function i.e. not effective in DMT1)
Why can’t sulphonylureas be used for DMT1?
Only effective in patients with residual pancreatic function
Adverse effects/contraindications of sulphonylureas (gliclazide)
*Hypoglycaemia
*GI disturbances - WEIGHT GAIN
(more seriously hypoglycaemia can occur, especially when used with other hypoglycaemic medications)
- Hypersensitivity reactions causing hepatic toxicity, rash and fever and haematological abnormalities (rare)
- Use with care in hepatic impairment and renal impairment, and in people at increased risk of hypoglycaemia
- Risk of hypoglycaemia is increased by drugs such as metformin, glitazone and insulin
- Efficacy is reduced by prednisolone, thiazide and loop diuretics which increase glucose
What drugs run risk of hypoglycaemia if used alongside sulphonylureas?
Metformin
Glitazone
Insulin
Give an example of a glitazone
Pioglitazone
Indications of (pio)glitazone
DMT2
alone if metformin is contraindicated or in combination with metformin or a sulphonylurea when glucose levels are uncontrolled
Mechanisms of (pio)glitazone
-Activates peroxisome proliferator-activated receptors (PPARs)
bind free fatty acids and induce genes that enhance insulin action in skeletal muscle, adipose tissue and the liver
- Increases peripheral glucose uptake and utilisation and reduces hepatic gluconeogenesis
- Increase in the storage of fatty acids in adipocytes, decreasing the amount present in circulation
Why does (pio)glitazone have low hypoglycaemia risk?
as does not stimulate pancreas
Adverse effects/contraindications of (pio)glitazone
- Fluid retention (increases Na+ reabsorption) - may worsen HF
- Weight gain (fluid retention + fat gain)
- Increased fracture risk, peripheral oedema, anaemia and mild weight gain
- Increases risk of bladder cancer
- Lower risk of hypoglycaemia than other agents - but risk is increased in combination
- Contraindicated in those with heart failure, DMT1 and diabetic ketoacidosis
and must be used with care in hepatic impairment
Examples of insulins
Insulin aspart Insulin glargine Biphasic insulin Soluble insulin Isophane insulin
Indications of insulins
- Insulin replacement in people with DMT1 and for the control of blood glucose in those with DMT2 where oral hypoglycaemic treatment is inadequate or poorly tolerated
- Given IV in diabetic emergencies such as diabetic ketoacidosis and hyperglycaemic hyperosmolar state
Mechanisms of insulins
- Stimulates glucose uptake from the circulation into tissue and increases the use of glucose as an energy source
- Stimulates glycogen, lipid and protein synthesis and inhibits gluconeogenesis and ketogenesis
Different insulin preparations
rapid acting (insulin aspart), short acting (soluble insulin), intermediate acting (isophane insulin) and long acting (insulin glargine)
What is biphasic insulin
contains a mixture of rapid and intermediate acting insulin
Adverse effects/contraindictions of insulins
HYPOGLYCAEMIA
which can cause lipohypertrophy (fatty lumps) if administered by injection in the same site
- Use with care in renal impairment as there is an increased risk of hypoglycaemia
- Combinations with other hypoglycaemic agents increases risk of hypoglycaemia and use with corticosteroids increases the dose required to have same effect
Example of thyroid replacement drug hormone
Levothyroxine (synthetic T4)